Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 160

The DOI matches its Crossref record.

Peptidomimetic Regulation of Growth Hormone Secretion

Smith, R. G. · 1997 · Endocrine Reviews

Abstract

HORMONES are generally released episodically, yet to our knowledge no attempt has been made to design drugs for treating hormone deficiencies that imitate or amplify the endogenous oscillators governing pulsatile hormone release. For example, although GH is normally secreted in a pulsatile manner with peaks occurring approximately every 3 h, GH deficiency is treated by injecting recombinant GH either once daily or every 3 days. Clearly, this dosing regimen does not result in a physiological GH profile and urges the development of a more natural approach for the treatment of GH deficiency. For convenience to the patient, a pathway was sought that could be activated by a drug given orally once daily. By design, conventional peptides were excluded, because the molecular template had to be readily manipulable for optimization of oral absorption and pharmacokinetics. A receptor that controlled GH release by interaction with an endogenous small molecule was unknown, necessitating a heterodox approach to drug discovery. This reverse pharmacology involved: 1) establishing assays for the functional endpoint, stimulation of episodic GH release; 2) understanding at the cellular level how known peptides controlled GH release so that new specific targets of intervention could be selected; 3) identifying selective GH secretagogues of appropriate structure for optimization of pharmacokinetic properties; 4) characterizing and cloning the receptor for these ligands; and 5) identifying the receptor’s natural ligand. This review provides a summary of points 1–4, focusing on the discovery and properties of new GH secretagogues. These molecules were subsequently shown to be peptide mimetics of the GH-releasing peptides (GHRPs) first identified by the pioneering work of Bowers, Momany, and colleagues (1–3); for a comprehensive review of GHRPs the reader is referred to Refs. 4–9. The natural ligand for the receptor activated by GHRPs and its peptidomimetics remains elusive, but now that the receptor has been cloned and distributed, we anticipate its ligand will soon be discovered.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/er.18.5.621

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 160

Metadata

Authors
Smith, R. G.
Venue
Endocrine Reviews
Published
1997-10-01
Volume
18
Issue
5
Pages
621-645
ISSN
0163-769X (ISSN-L)
OpenAlex
W4239095299
Cited by
160
References
0
FWCI
7.30
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peptidomimetic Regulation of Growth Hormone Secretion. https://app.cochat.ai/papers/10.1210/er.18.5.621
The paper
Smith, R. G. (1997). Peptidomimetic Regulation of Growth Hormone Secretion. Endocrine Reviews. https://doi.org/10.1210/er.18.5.621

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.